These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Response to pneumococcal vaccine in the elderly: no enhancement by indomethacin. Lafferty WP; Selinger DS; Schiffman G; Goodwin JS J Immunopharmacol; 1981; 3(2):241-50. PubMed ID: 7338631 [TBL] [Abstract][Full Text] [Related]
31. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae. Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973 [TBL] [Abstract][Full Text] [Related]
32. Pneumococcal antibodies measured with a rapid enzyme-linked-immunosorbent assay (ELISA), using the whole vaccine as antigen. Suggestions for clinical application. Snijder JA; Löwenberg A; Klompmaker I; Weits J Neth J Med; 1988 Aug; 33(1-2):52-9. PubMed ID: 3247011 [No Abstract] [Full Text] [Related]
33. Polyvalent pneumococcal polysaccharide vaccines. Hilleman MR; McLean AA; Vella PP; Weibel RE; Woodhour AF Bull World Health Organ; 1978; 56(3):371-5. PubMed ID: 28857 [TBL] [Abstract][Full Text] [Related]
34. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. Sorensen RU; Leiva LE; Javier FC; Sacerdote DM; Bradford N; Butler B; Giangrosso PA; Moore C J Allergy Clin Immunol; 1998 Aug; 102(2):215-21. PubMed ID: 9723664 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay. Kim KH; Seoh JY J Korean Med Sci; 1999 Oct; 14(5):475-9. PubMed ID: 10576141 [TBL] [Abstract][Full Text] [Related]
36. Occurrence of idiotypically identical antibodies in the sera of two outbred rabbits hyperimmunized with type II pneumococcal vaccine. Brandt DC; Jaton JC J Immunol; 1978 Sep; 121(3):1188-93. PubMed ID: 29067 [No Abstract] [Full Text] [Related]
37. Antibody responses to pneumococcal capsular polysaccharide: what is being measured? Goldblatt D; Jadresic LP; Levinsky RJ; Turner MW Immunodeficiency; 1993; 4(1-4):47-50. PubMed ID: 8167732 [No Abstract] [Full Text] [Related]
38. Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharide-protein vaccines. Zigterman GJ; Snippe H; Jansze M; Ernste EB; De Reuver MJ; Willers JM Infect Immun; 1988 May; 56(5):1391-3. PubMed ID: 3356469 [TBL] [Abstract][Full Text] [Related]
39. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies. Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273 [TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model. Giebink GS; Meier JD; Quartey MK; Liebeler CL; Le CT J Infect Dis; 1996 Jan; 173(1):119-27. PubMed ID: 8537648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]